Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Bill Greene
AddedFeb 13, 2024
UpdatedMay 31, 2026
Bill Greene

Bill Greene

Board Member, Neovista

CrunchbaseThe Org

Bill Greene's Career

Neovista
Neovista

Newark, CA, US

Board Member· Board
Iconic Therapeutics
Iconic Therapeutics

South San Francisco, CA, US

CEO· C-Suite · Management
EndoGastric Solutions
EndoGastric Solutions

Redmond, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Bill Greene's Career

Neovista
Neovista
Series A$156.9M142002Newark, CA, US
Board Member· Board

Leadership at Neovista

Ryan SchwarzRyan SchwarzBoard Member
David GyorkeDavid GyorkeBoard Member
Charles LarsenCharles LarsenFounder
David GuyerDavid GuyerBoard Member
Gerard Van Hamel PlaterinkGerard Van Hamel PlaterinkBoard Member
John N. HendrickJohn N. HendrickBoard Member
Iconic Therapeutics
Iconic Therapeutics
Acquired$82.8M02002South San Francisco, CA, US
CEO· C-Suite · Management

Leadership at Iconic Therapeutics

Johan KördelJohan KördelBoard Member
Todd FoleyTodd FoleyBoard Member
Bruce RobertsonBruce RobertsonBoard Member
Kirk DornbushKirk DornbushCo-Founder
Michael ShermanMichael ShermanCo-Founder
Julia P GregoryJulia P GregoryBoard Member

Similar to Iconic Therapeutics

Eikon TherapeuticsEikon TherapeuticsHayward, CA, USBiopharmaceuticalsest. 2019Eikon TherapeuticsHayward, CA, US · est. 2019

Eikon Therapeutics: A biopharmaceutical firm innovating novel treatments for critical diseases.

Series C · $772M374
Imagen BiotechImagen BiotechNew York City, NY, USTherapeuticsest. 2011Imagen BiotechNew York City, NY, US · est. 2011

Imagen Biotech: Pioneering solutions for blinding diseases through innovative therapeutics.

Series A · $40M30
IkariaIkariaHampton, NJ, USPharmaceuticalsest. 2006IkariaHampton, NJ, US · est. 2006

Ikaria, Inc. innovates and patents novel therapeutic pharmaceuticals.

Series D · $344.9M750
ComplexaComplexaPittsburgh, PA, USTherapeuticsest. 2008ComplexaPittsburgh, PA, US · est. 2008

Complexa, Inc.: A biopharmaceutical firm innovating therapies for inflammatory and metabolic diseases.

Public · $86.9M7
EndoGastric Solutions
EndoGastric Solutions
Series B$380.2M922003Redmond, WA, US
Board Member· Board

Leadership at EndoGastric Solutions

Arda MinocherhomjeeArda MinocherhomjeeBoard Member
Darin HammersDarin HammersBoard Member
Alejandro SanchezAlejandro SanchezBoard Member
Joe MandatoJoe MandatoBoard Member
Brent AhrensBrent AhrensBoard Member
Jordan S. DavisJordan S. DavisBoard Member

Similar to EndoGastric Solutions

EndoSoundEndoSoundPortland, OR, USMedical Devicesest. 2016EndoSoundPortland, OR, US · est. 2016

EndoSound: Pioneering technology for advanced endoscopic ultrasound solutions.

Angel · $410.8k12
Max EndoscopyMax EndoscopyMacedonia, OH, USMedical Devicesest. 2007Max EndoscopyMacedonia, OH, US · est. 2007

MAX Endoscopy: Innovating cost-effective endoscopic devices for enhanced GI treatments.

Seed · $385k6
EvoEndoEvoEndoEnglewood, CO, USMedical Devicesest. 2017EvoEndoEnglewood, CO, US · est. 2017

EvoEndo: Innovating unsedated endoscopic procedures with sterile, single-use systems.

Series B · $19M16

Bill Greene's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Bill Greene

William GreeneWilliam GreeneCo-Founder · Pear TherapeuticsJason BallardJason BallardCo-Founder · IconPaul StephensPaul StephensFounder · Iconic FinancialRichard DeCiccoRichard DeCiccoBoard Member · Iconic BrandsMr. Cary P. HaganMr. Cary P. HaganCEO · BarricaidDavid S TierneyDavid S TierneyBoard Member · Viatar CTC Solutions